The rising prevalence, driven by aging populations, lifestyle changes, and environmental factors, is fueling substantial market growth. According to the American Cancer Society, approximately 1.96 million new cancer cases and 609,820 cancer-related deaths are expected in the U.S. in 2023. This surge has increased demand for treatments, diagnostic tools, and therapies, prompting advancements in pharmaceuticals and healthcare solutions. Ongoing research, improved early detection methods, and innovative therapies further contribute to the segment’s market dominance.
Key Insights
The rise of digital healthcare services, including online prescriptions and teleconsultations, is expected to support continued market growth. The Europe prescription drugs market is projected to expand at a substantial CAGR throughout the forecast period, supported by universal healthcare systems, a focus on cost-effective drug access, and robust pharmacovigilance mechanisms. This dominance is attributed to the increasing prevalence of chronic diseases, the rise in research and development (R&D) efforts, and the continuous introduction of novel therapeutics. However, the expiration of patents for branded drugs and the growing presence of generics may hinder this segment’s growth. The generic drug segment is expected to expand rapidly, driven by the approval of Abbreviated New Drug Applications (ANDAs) and increased demand for affordable medications. The hospital pharmacy segment plays a critical role in the space, accounting for a substantial share of the overall pharmaceutical distribution landscape.
Thus, the rebound in the number of hospital visits by patients’ post-pandemic, coupled with the high consumption of prescription drugs in homecare settings, boosted the global prescription drugs market growth. Asia Pacific is expected to be the fastest-growing region in the projected timeframe, as a rising number of aging populations with chronic conditions like hypertension, diabetes, and dementia are significantly driving the growth of the drugs market. Although novel advanced technologies in drug delivery, including nanotechnology, microencapsulation, and 3D printing, are optimizing drug efficacy and bioavailability, which leads to the enhanced demand for drugs. Around the world, the number of pharmaceutical companies is moving towards advancing treatments customized to each patient, depending on their genetic characteristics and disease pattes. Also, incorporating biologics, like monoclonal antibodies and cell therapies, is predicted to play a consistently significant role in treating complex conditions like cancer and autoimmune disorders.
Market Share Of Leading 10 National Pharmaceutical Markets Worldwide In 2024
Totalinflation-adjusted expenditures on prescription drugs grew from $522billion in 2017 to $618 billion in 2022, an 18.4 percent increase. Totalprescriptions had a similar percentage point increase, from 8.019billion in 2017 to 9.315 billion in 2022 (a 16.2 percent increase). Theincrease in total expenditures was driven by a 54.6 percent increase inexpenditures on biological products, from $163 billion in 2017 to $252billion in 2022.
Rising prevalence of chronic diseases, favorable regulatory policies, rising healthcare spending, growth in biologics and biosimilars. It focuses on key features such as the prevalence of key diseases – by key countries – pipeline analysis, key industry developments, new product approvals, and regulatory scenarios – by key regions. Also, the report offers insights into the market trends and highlights key industry developments. In addition to the above-mentioned factors, the report includes numerous factors that have contributed to the growth of the market in the recent years. The impacting factors are accelerating healthcare expenses in both public and private sectors, which are fueling demand for drugs.
In Figure 2-2 with a relatively flat demand curve (i.e., one that is very responsive to price changes), the supply-side intervention causes a relatively small increase in the market price to P2’. Under this hypothetical situation, the war on drugs has worked quite well by sharply reducing the quantity of drugs consumed to Q2’. However, precisely because drug demand is so responsive to the higher prices caused by the intervention, the price does not have to increase much to restore equilibrium. In contrast, the sharp increase in price seen in Figure 2-1 is accompanied by a smaller reduction in the quantity of drugs consumed—the war on drugs did not work that well.
Submission: AbbVie Targets Psychedelic-Based Depression Drug Market With $12 Billion Deal
As of March 2022, specialty medicines accounted for 55% of net spending, up from 28% in 2011. Prescription drugs require a prescription from a healthcare professional, while over-the-counter drugs can be purchased directly from a pharmacy or store without a prescription. A prescription drug is a medication that can only be obtained with a valid prescription from a licensed healthcare professional, such as a doctor or a nurse practitioner. Prescription drugs play a vital role in modern healthcare, providing effective treatments for a wide range of medical conditions. The U.S. pharmacy market is expected to grow at a compound annual growth rate of 3.67% from 2023 to 2030 to reach USD 708.9 billion by 2030. Market players adopt this strategy to expand the outreach of their service in the market and increase the availability of their service in diverse geographical areas.
Pharmaceutical Market Size And Forecast 2025 To 2034
In addition, the demand for self-medication, cost-effective treatment options, and the availability of prescription fulfillment services further enhance the segment’s growth prospects. The hospital pharmacy segment dominated the peptide drug conjugates market with a revenue share of 53.53% in 2024 due to increasing hospital admissions, rising demand for specialized treatments, and access to a wide range of prescription medications. Hospitals serve as primary points for acute care, chronic disease management, and surgical procedures, driving medication demand through in-house pharmacies. The availability of advanced therapies, including biologics and injectable drugs, further supports this dominance.
Leading Companies
Addiction is also an important and distinctive feature of the illegal drug market, though it is also important for the markets for tobacco, alcohol, and caffeine. A sophisticated literature exists to explore the supply and demand sides of these markets for addictive legal products. In many analyses, researchers examined variations across the states in tobacco and beer excise taxes to explore supply-demand models (see, e.g., Cook and Moore, 1993; Grossman, 2004). Given evidence that producers pass almost the entire excise tax burden to consumers, these analyses provide reasonable estimates of consumers’ demand response to increased prices.
US Pharmaceutical Market Trends
This study relied heavily on the Washington, DC, study noted above (Reuter et al., 1990), which found that compensation for the risks of deaths, injury, and incarceration accounted for approximately $21,000 per dealer annually. Made in units of 100 milligrams of pure cocaine, then this gang made only 1,000 transactions per month. With 30 street dealers, this would total about two sales per dealer per day, assuming that individuals sell only about half the days of the year. The Chicago gang records are consistent with very occasional selling on the part of participants, but that can not be reconciled with the authors’ estimate that the street dealers average 20 hours a week selling (Levitt and Venkatesh, 2000, p. 10).
For instance, in March 2022, Walgreens Boots Alliance reported opening its robotic micro-fulfillment centers in its 22 facilities across the United States, to fill customers’ prescriptions. Moreover, According to the Centres for Disease Control and Prevention, approximately 198 million flu shots were available in 2020, compared to 175 million in the previous year. CVS, which administered 9 million shots in 2019, is anticipated to reach 18 million in 2020. Similarly, Rite Aid, which provided 2.6 million shots in 2019, ordered 3.9 million in 2020. The increase in revenue from administering vaccines and providing telehealth services has led to an expansion of pharmacy services in the U.S.
Other Statistics On The TopicPharmaceutical Industry In The US
Funding assists generic drug manufacturers in meeting these regulatory compliance standards, such as conducting clinical trials, obtaining necessary certifications, and meeting manufacturing facility requirements. Adequate funding enables manufacturers to navigate the regulatory landscape and gain necessary approvals for their generic products. In addition, funding plays a crucial role in establishing and expanding the manufacturing infrastructure for generic drugs. This includes investments in state-of-the-art facilities, equipment, and technologies that meet Good Manufacturing Practices (GMP) standards. Adequate funding allows generic drug manufacturers to build robust manufacturing capabilities, ensure product quality, and scale up production to meet market demand.
Increased funding facilitates market entry strategies, such as conducting market assessments, obtaining necessary licenses, and adapting products to meet specific regional requirements. The adult segment dominated the market by holding the largest revenue share of 64% in 2024 due to rising chronic disease prevalence in adults. The healthcare spending has increased, creating thr need for cost-effective and easily accessible medications. Moreover, the increased prevalence of obesity among adults boosts the demand for pharmaceuticals.
- Thus, the growing number of approvals of generic drugs drives the US pharmaceutical market share and demand for generic segment.
- The oral segment accounted for the largest revenue share of 51.2% in 2024, due to ease of use and widespread application in chronic disease management.
- The online pharmacy segment is projected to record the fastest CAGR of 9.2% from 2025 to 2032, fueled by growing digital health trends, doorstep delivery models, and convenience for chronic users.
- The scale of the pharmaceutical industry in the United States is enormous.29 The markets in developing countries are comparatively more diverse, with groups with higher purchasing power investing more in innovation and those with lower purchasing power investing more in generics.
- Based on type, the conventional drugs (small molecules) segment accounted for the largest revenue share of 54.74% in 2024, due to their well-established manufacturing process, predictable pharmacokinetics, and oral bioavailability.
By therapeutic application, the diabetes segment held a dominant presence in the generic drugs market in 2024. The rising prevalence of diabetes and increasing healthcare costs of diabetes treatment necessitate the use of generic drugs. Diabetes is non-curable but can go into remission, i.e., the body does not show any signs of diabetes, but the disease is still present. Generic drugs can drastically reduce the financial burden on low- and middle-income groups and increase medication adherence. Furthermore, funding supports generic drug manufacturers in expanding their market reach and distribution networks.
Those who remain tethered to the old model of competing solely on the price of simple generics will find themselves in an increasingly precarious position, squeezed by commoditization on one side and technological obsolescence on the other. This dynamic is likely to accelerate market consolidation, as larger, more technologically advanced players acquire smaller competitors or force them from the market. In January 2025, Sunshine Biopharma Inc. announced the release of two new generic prescription drugs by its Canadian subsidiary, Nora Pharma Inc. Dr. Steve Slilaty, CEO of Sunshine Biopharma, commented that the launch of two generic drugs could fulfill the company’s commitment to expand its presence in the Canadian generic drug market. The illegal drug trade, drug trafficking, or narcotrafficking is a global black market dedicated to the cultivation, manufacture, distribution and sale of prohibited drugs.
